Mycoplasma pneumoniae-associated myelitis: a comprehensive review
Related Experiment Video
Updated: Aug 11, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
S Tsiodras1, Th Kelesidis, I Kelesidis
1Fourth Academic Department of Internal Medicine and Infectious Diseases, Attikon University Hospital, University of Athens Medical School, Athens, Greece. tsiodras@med.uoa.gr
Abstract:
Myelitis is one of the most severe central nervous system complications seen in association with Mycoplasma pneumoniae infections and both acute transverse myelitis (ATM) as well as acute disseminated encephalomyelitis (ADEM) have been observed. We reviewed all available literature on cases of Mycoplasma spp. associated ATM as well as ADEM with dominant spinal cord pathology and classified those cases according to the strength of evidence implicating M. pneumoniae as the cause. A wide range of data on diagnosis, epidemiology, immunopathogenesis, clinical picture, laboratory diagnosis, neuroimaging and treatment for this rare entity is presented. The use of highly sensitive and specific molecular diagnostic techniques may assist in clearly elucidating the role of M. pneumoniae in ATM/ADEM syndromes in the near future. Immunomodulating therapies may have a role in treating such cases.
Insights
Mycoplasma pneumoniae infections can cause severe central nervous system complications like acute transverse myelitis (ATM) and acute disseminated encephalomyelitis (ADEM). Further research using molecular diagnostics is needed to confirm M. pneumoniae
Area of Science:
- Neuroimmunology
- Infectious Diseases
- Neurology
Background:
- Myelitis, including acute transverse myelitis (ATM) and acute disseminated encephalomyelitis (ADEM), is a severe central nervous system complication associated with Mycoplasma pneumoniae infections.
- While M. pneumoniae is implicated, the exact causal link and pathogenesis in these neurological syndromes require further elucidation.
Purpose of the Study:
- To review and classify existing literature on Mycoplasma spp.-associated ATM and ADEM with spinal cord pathology.
- To consolidate information on the diagnosis, epidemiology, immunopathogenesis, clinical presentation, laboratory findings, neuroimaging, and treatment of these rare neurological conditions.
Main Methods:
- Systematic literature review of cases of Mycoplasma spp.-associated ATM and ADEM with dominant spinal cord pathology.
- Classification of cases based on the strength of evidence implicating M. pneumoniae as the causative agent.
Main Results:
- Mycoplasma pneumoniae is a potential cause of ATM and ADEM, particularly those with significant spinal cord involvement.
- The review compiles data on various aspects of these rare neurological syndromes, highlighting diagnostic challenges and therapeutic considerations.
Conclusions:
- The precise role of M. pneumoniae in ATM/ADEM syndromes necessitates further investigation, particularly utilizing advanced molecular diagnostic techniques.
- Immunomodulating therapies show promise as a treatment strategy for these M. pneumoniae-associated neurological complications.
Related Concept Videos
Atypical Pneumonia
Bacterial Meningitis I: Introduction
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis
Pneumonia III: Complications and Assessment